Pinnacle Medicines Overview

  • Year Founded
  • 2024

Year Founded

  • Status
  • Private

  • Employees
  • 18

Employees

  • Latest Deal Type
  • Series B

  • Latest Deal Amount
  • $89M

  • Investors
  • 8

Pinnacle Medicines General Information

Description

Operator of a peptide drug discovery company intended to transform patients' lives through oral peptide therapeutics. The company utilizes artificial intelligence-based drug design tools for research, offering medical companies safe, effective, and convenient therapeutics to address unmet medical needs.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Doylestown, PA
  • United States
+1 (215)
Primary Industry
Drug Discovery
Corporate Office
  • Doylestown, PA
  • United States
+1 (215)

Pinnacle Medicines Timeline

20252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Pinnacle Medicines Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC (Series B) 26-Mar-2026 $89M Completed Generating Revenue
1. Early Stage VC 26-Feb-2024 Completed Generating Revenue
To view Pinnacle Medicines’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Pinnacle Medicines Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Pinnacle Medicines Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds
Foresite Capital Growth/Expansion Minority
Hankang Capital Growth/Expansion Minority
LAV (Lilly Asia Fund) Corporate Venture Capital Minority
Logos Capital Hedge Fund Minority
Quan Capital Venture Capital Minority
You’re viewing 5 of 8 investors. Get the full list »

Pinnacle Medicines FAQs

  • When was Pinnacle Medicines founded?

    Pinnacle Medicines was founded in 2024.

  • Where is Pinnacle Medicines headquartered?

    Pinnacle Medicines is headquartered in Doylestown, PA.

  • What is the size of Pinnacle Medicines?

    Pinnacle Medicines has 18 total employees.

  • What industry is Pinnacle Medicines in?

    Pinnacle Medicines’s primary industry is Drug Discovery.

  • Is Pinnacle Medicines a private or public company?

    Pinnacle Medicines is a Private company.

  • What is Pinnacle Medicines’s current revenue?

    The current revenue for Pinnacle Medicines is .

  • How much funding has Pinnacle Medicines raised over time?

    Pinnacle Medicines has raised $134M.

  • Who are Pinnacle Medicines’s investors?

    Foresite Capital, Hankang Capital, LAV (Lilly Asia Fund), Logos Capital, and Quan Capital are 5 of 8 investors who have invested in Pinnacle Medicines.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process